Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,390.00    -65.00 (-1.19%)
Bid:
5,410.00
Ask:
5,420.00
Spread: 10.00 (0.185%)
Market Cap: £3.92b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Interim Management Statement

15 May 2009 07:00

RNS Number : 2860S
Renishaw PLC
15 May 2009
 



Renishaw plc

Interim Management Statement

15 May 2009

As indicated in our trading update in March, trading conditions remain weakWe are however focussed on client service, continuing investment in our existing portfolio of products, research & development, and on newer markets such as spectroscopy, dental, neuro and advanced metrology equipment. The launch of our new dental product range took place at the International Dental Exhibition at the end of March and a portfolio of new products for the Neurosurgical market is to be launched at the fifteenth Quadrennial Meeting of the World Society of Stereotactic and Functional Neurosurgery, being held in Toronto at the end of this month. Early interest from prospective customers is encouraging.

The Group's order book visibility still remains short. However, the Group's cost base has been stream-lined as a result of the cost saving measures initiated by the Group earlier in the financial year and this will mitigate the impact of the ongoing difficult market conditions on the level of profitability. The Group still expects to record an operating loss (before exceptional, one-off items) in the second half of the year, although it is now expected to be somewhat lower than the £10 million previously indicated.

The Group has a strong balance sheet and management action has resulted in an overall reduction in the level of the working capital requirement. Net cash balances at the end of April were £14m.

The Group's strength in its key markets and its continued investment in the business ensures that it is well-positioned to benefit from the eventual improvement in demand and the Board remains confident of the Group's long-term prospects.

Sir David R McMurtry, CBE, RDI, CEng, FIMechE, FREng

Chairman & Chief Executive

Enquiries: B R Taylor 01453 524445

A C G Roberts 01453 524445

Registered number: 1106260

Registered office: New Mills, Wotton-under-Edge, Gloucestershire. GL12 8JR

Telephone: 01453 524524

Website: www.renishaw.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSAIMATMMJBBJL
Date   Source Headline
16th May 20239:45 amRNSAGM Voting Results Update Statement
9th May 20233:39 pmRNSNotice of Investor Day
28th Apr 20237:00 amRNSTrading Statement
2nd Feb 20237:00 amRNSHalf-year Report
24th Jan 20233:11 pmRNSNotice of Half-year Results
30th Nov 20224:38 pmRNSResult of AGM
31st Oct 20221:00 pmRNSNotice of AGM
28th Oct 20229:15 amRNSDirector/PDMR Shareholding
27th Oct 20227:00 amRNSTrading Statement
30th Sep 20227:00 amRNSAnnual Financial Report
29th Sep 202210:12 amRNSDirector/PDMR Shareholding
15th Sep 20227:00 amRNSFinal Results
6th Sep 20221:00 pmRNSNotice of Results
1st Jul 202212:31 pmRNSDirector Declaration
16th May 20225:56 pmRNSDirector/PDMR Shareholding
16th May 20227:00 amRNSAGM Voting Results Update Statement
10th May 20227:00 amRNSTrading Statement
12th Apr 202211:44 amRNSNotice of Investor Day
12th Apr 202210:58 amRNSDirector/PDMR Shareholding
31st Mar 20221:00 pmRNSDirectorate Change
18th Mar 20222:08 pmRNSHolding(s) in Company
14th Mar 20225:58 pmRNSDirector/PDMR Shareholding
1st Mar 20224:23 pmRNSDirectorate Change
3rd Feb 20227:00 amRNSHalf-year Report
17th Jan 20221:00 pmRNSNotice of Half-year Results
20th Dec 20214:05 pmRNSDirectorate Change
24th Nov 20213:57 pmRNSResult of AGM
29th Oct 20218:00 amRNSDirector/PDMR Shareholding
29th Oct 20217:00 amRNSAnnual Financial Report
21st Oct 202111:50 amRNSFinal Results Replacement
21st Oct 20217:00 amRNSFinal Results
21st Oct 20217:00 amRNSTrading Statement
27th Sep 202110:52 amRNSFinal Results Revised Date and Trading Update
17th Sep 202110:35 amRNSNotice of Results
31st Aug 202112:31 pmRNSHolding(s) in Company
3rd Aug 20213:05 pmRNSDirector/PDMR Shareholding
8th Jul 20213:20 pmRNSForm 8.3 - Renishaw plc
8th Jul 20217:00 amRNSForm 8.3
7th Jul 20213:20 pmRNSForm 8.3 - Renishaw plc
7th Jul 20213:13 pmRNSForm 8.3 - Renishaw plc
7th Jul 20212:26 pmEQSForm 8.3 - The Vanguard Group, Inc.: Renishaw plc
7th Jul 202111:48 amRNSForm 8.5 (EPT/NON-RI) - Renishaw plc
7th Jul 202111:14 amRNSForm 8.5 (EPT/RI) - Renishaw Plc
7th Jul 20217:00 amRNSUpdate on Formal Sale Process & Current Trading
6th Jul 20213:20 pmRNSForm 8.3 - Renishaw plc
6th Jul 20213:09 pmRNSForm 8.3 - Renishaw plc
6th Jul 20212:38 pmRNSForm 8.3 - Renishaw Plc
6th Jul 20212:13 pmRNSForm 8.3 - Renishaw Plc
6th Jul 20212:05 pmEQSForm 8.3 - The Vanguard Group, Inc.: Renishaw plc
6th Jul 202111:36 amRNSForm 8.5 (EPT/RI) - Renishaw Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.